Responsibilities/岗位职责:

Position Overview

• The position has the general responsibility for securing continuity of Shanghai site raw materials supply.
• The candidate will be able to navigate through a large complex business and solve problems.
• Strong project management and multi-functional communication skills are required to provide the linkage with other internal and external functions.

Job Scope and Main Activities

• Analyze end user RFQ and search/select/negotiate with suppliers.
• Develop strategies for key supplier, process and performance management.
• Lead contract and price negotiations with assigned key suppliers.
• Lead communication of end user, with serve on your own initiative, guide a need and meet the demand.
• Place Purchasing Orders to suppliers to ensure on-time shipment to meet end user requirements.
• Collect supplier invoices and related documents and submit to Finance for supplier payment.
• Work together with import team to collect shipping documents from supplier and support custom clearance issue.
• Handle supplier quality issue.
• JDE purchasing data maintenance.
• Monitor and improve supplier performance according to supplier performance matrix.
• Responsible for implementation of Purchasing Control Police, working instructions and guidelines for users on how to deploy it.
• Continue drive process improvement.
• Other tasks assigned by leader.

Requirements/职位要求：

• Integrity.
• 5+ years experience in Procurement organizations and 2+ years of management position.
• Bachelor’s Degree in life science relative major, or working experiences in Biology related industry.
• Strong negotiation skills, presentation skills, interpersonal skills and leadership skills.
• Proven ability to execute and deliver on commitments with strong business acumen.

Goal-oriented, assertive, logical thinking, detail driven with can-do spirit.

上班地址：马山梅梁路108号

所属部门：全球供应链部

药明生物（股票代码：2269.HK）作为一家香港上市公司，是全球领先的开放式、一体化生物制药能力和技术赋能平台。公司为全球生物制药公司和生物技术公司提供全方位的端到端研发服务，帮助任何人、任何公司发现、开发及生产生物药，实现从概念到商业化生产的全过程，加速全球生物药研发进程，降低研发成本，造福病患。截至2018年6月30日，在药明生物平台上研发的综合项目达187个，包括98个处于临床前研究阶段，78个在临床早期（I期，II期）阶段，10个在后期临床（III期）以及1个在商业化生产阶段。预计到2021年，公司在中国、爱尔兰、新加坡、美国规划的生物制药生产基地合计产能约22万升，这将有力确保公司通过健全强大的全球供应链网络为客户提供符合全球质量标准的生物药。如需更多信息，请访问：www.wuxibiologics.com.cn。
药明生物员工总数超过4000人，其中300多位是具有海外高等学位和工作经验的海归科学家，拥有欧美市场抗体开发、生产、质量控制、临床前研究和国际注册经验，高级管理层团队成员均工作在生物制药行业一线，并在各自专业领域平均拥有超过20年行业经验，打造了世界一流的生物药发现、开发及生产团队。